Inhibition by adriamycin of the mitochondrial biosynthesis of coenzyme Q10 and implication for the cardiotoxicity of adriamycin in cancer patients
In: Biochemical and Biophysical Research Communications, Jg. 77 (1977-08-01), S. 1536-1542
Online
unknown
Zugriff:
Summary Steps were standardized as a control system for the mitochondrial biosynthesis of coenzyme Q 10 from radioactive p-hydroxybenzoic acid. In this system, adriamycin inhibited the biosynthesis. Adriamycin and the reference inhibitor of the functionality of CoQ 10 -enzymes at the same concentration gave the same inhibition of biosynthesis. Whatever the mechanism(s) may be for this inhibition by adriamycin of biosynthesis of CoQ 10 , in conjunction with the known inhibition by adriamycin of the functionality of CoQ 10 -enzymes, the net result could partially account for the cardiotoxicity of adriamycin in cancer patients. Administration of CoQ 10 to such patients could circumvent depressed biosynthesis and the inhibition of CoQ 10 -enzymes with some possible reduction of cardiotoxicity.
Titel: |
Inhibition by adriamycin of the mitochondrial biosynthesis of coenzyme Q10 and implication for the cardiotoxicity of adriamycin in cancer patients
|
---|---|
Autor/in / Beteiligte Person: | Porter, Thomas H. ; Watanabe, Tatsuo ; Folkers, Karl ; Liu, Margaret |
Link: | |
Zeitschrift: | Biochemical and Biophysical Research Communications, Jg. 77 (1977-08-01), S. 1536-1542 |
Veröffentlichung: | Elsevier BV, 1977 |
Medientyp: | unknown |
ISSN: | 0006-291X (print) |
DOI: | 10.1016/s0006-291x(77)80152-6 |
Schlagwort: |
|
Sonstiges: |
|